Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63324	355	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
62868	No insight on MRNS. I bought some after the plunge in April, but I see that Avor	ghettogoulash	-	10/20/2024
62867	To pull a drug in P3 that has almost finished the trial when there is no safety	stockdoc77	2	10/19/2024
62866	Makes the sale to Gilead look better and better with hindsight. Behzad got us t	stockdoc77	8	10/19/2024
62865	ca.finance.yahoo.com	mannamal	-	10/18/2024
62864	Not surprisingly that article is pretty one sided IMO.	erippetoe	-	10/13/2024
62863	doximity.com	urslor	-	10/13/2024
62862	finance.yahoo.com	jargonweary	-	10/10/2024
62861	Jargon, is that GILD's Q2 results? Seems early for Q3 to be released alread	KeeptheFaith	-	10/10/2024
62860	From Gilead’s earnings call: Gilead's oncology segment showed strong growth	jargonweary	7	10/10/2024
62859	finance.yahoo.com	sysiphus	-	10/10/2024
62858	For any of those in the Florida region, especially Tampa area and surrounding ..	luckydog88	3	10/8/2024
62857	HC Wainwright & Co. analyst Vernon Bernardino upgrades Cassava Sciences(SAVA	luckydog88	4	10/8/2024
62856	An Open Letter from President and CEO Rick Barry to the Cassava Community: Pati	luckydog88	4	10/8/2024
62855	I remember GhettoGoulash was looking closely at MRNS in the spring when MRNS sol	Olecranon	-	10/7/2024
62854	Does anyone here still follow Marinus? (MRNS) They’re due to report top line dat	Swedishlake	-	10/6/2024
62853	science.org	urslor	3	10/6/2024
62852	SEC: "the results no longer show a significant difference between placebo,	ghettogoulash	-	9/30/2024
62851	Funny how the FDA inspected Wang's lab, his Elisa machine, time stamped data	ghettogoulash	2	9/30/2024
62850	SAVA: Live Short Interest is 40% of the float, or 17M shares. The most compellin	ghettogoulash	1	9/30/2024
62849	Scorman: Thanks for the clarification. There's just too much strangeness he	erickerickson	-	9/27/2024
62848	Me? I guess I am just a sucker for a small fragile company with big potential bu	jargonweary	8	9/27/2024
62847	Sold the shares I bought this morning (I like to day trade and took advantage of	erippetoe	2	9/27/2024
62846	Erick, you are confusing a possible cherry picking on the original 64patient 28d	scorman1	3	9/27/2024
62845	Seems like a very valid decision to make. It is hard to reconcile the wording r	luckydog88	3	9/27/2024
62844	Well, I didn't get out to the treehouse before deciding to get out. The &qu	erickerickson	1	9/27/2024

Go to reply# or date (mm/dd/yy):